Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microplasmin for VMA in Wet AMD
NCT00996684Phase 2Unknown
- Sponsor
- University of California, Los Angeles
- Start
- Oct 2009
- Primary completion
- Sep 2011
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ocriplasmin in vitreomacular adhesion (VMA), exudative macular degeneration, sponsored by University of California, Los Angeles. Status: unknown.
02
Drugs
ocriplasmin
03
Conditions
vitreomacular adhesion (VMA)exudative macular degeneration
Beyond the preview
Go deeper on NCT00996684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00996684.